最終更新日:2025/11/28
(pharmacology) A drug that blocks the activity of interleukin-1 and is administered as a subcutaneous injection chiefly in the treatment of rheumatoid arthritis. It is a recombinant form of an endogenous antagonist of interleukin-1 receptor and is marketed under the trademark Kineret.
音声機能が動作しない場合はこちらをご確認ください
正解を見る
anakinra
編集履歴(0)